登录 | 注册
FDI-6下调FoxM1抑制人肝癌细胞增殖迁移
FDI-6 down-regulation of FoxM1 inhibits proliferation and migration of human hepatocellular carcinoma cells
ES评分 0 浏览量:724 下载量:0
长沙医学院 湖南长沙 ;
[1] Shi J Y, Xing Q, Meng D, et al. Inferring the progression of multifocal liver cancer from spatial and temporal genomic heterogeneity[J]. Oncotarget. 2016, 7(3): 2867- 2877.
[2] Chino F, Stephens SJ, Choi SS. The role of external beam radiotherapy in the treatment of hepatocellular cancer, Cancer. 2018.
[3] Lu X F, Zeng, Liang W Q, et al. FoxM1 is a promising candidate target in the treatment of breast cancer[J]. Oncotarget. 2018, 9(1): 842-852.
[4] Yu M, Tang Z, Meng F, et al. Elevated expression of FoxM1 promotes the tumor cell proliferation in hepatocellular carcinoma[J]. Tumor Biology, 2016(1):1-9.
[5] Weiler S M E, Pinna F, Wolf T, et al. Induction of Chromosome Instability by Activation of Yes Associated Protein and Forkhead box M1 in Liver Cancer[J]. Gastroenterology, 2017, 152(8): 2037-2051.
[6] Bi Z, Liu W, Ding R, et al. A novel peptide, 9R-P201, strongly inhibits the viability, proliferation and migration of liver cancer HepG2 cells and induces apoptosis by down-regulation of FoxM1 expression[J]. European Journal of Pharmacology. 2017, 796: 175-189.
[7] Gormally M V, Dexheimer T S, Marsico G, et al. Suppression of the FoxM1 transcriptional program via novel small molecule inhibition[J]. Nature Communi- cations. 2014, 5(5):5165.
熊婷*,周迎. FDI-6下调FoxM1抑制人肝癌细胞增殖迁移 [J]. 国际临床研究杂志. 2022; 6; (10). 160 - 162.
Copyright © 2023 CSCIED科技核心评价数据库 版权所有 京ICP备
Email:info@cscied.com网址:www.cscied.com
互联网出版许可证违法和不良信息举报中心举报邮箱:jubao@cscied.com